Roamad Creative · Brand Strategy Sprint · Deliverable v1
Materia — integrative medical care for patients considering cannabis as therapy.
A San Francisco medical practice that treats cannabis as one therapeutic tool among many, prescribed only where the evidence supports it. Multi-state telehealth. Real consultations. Longitudinal care.
01 · Executive summary
One sentence: Materia is a real medical practice that treats cannabis as a clinical decision, not a transaction.
Materia is an integrative medicine practice founded by two San Francisco physicians, Dr. Sarah Liang (Stanford-trained pain medicine) and Dr. Marcus Okafor (UCSF-trained palliative care). The practice sees patients in person at a single Hayes Valley clinic and via licensed telehealth in California, New York, and Florida.
The model is longitudinal: a 45-minute initial consultation, a written care plan, quarterly follow-ups, and a clinical relationship that lasts beyond the issuance of a state medical-cannabis card. Cannabis is one of several therapies a Materia physician may discuss with a patient. It is never the reason a patient comes through the door — the patient’s condition is.
02 · The market gap
The medical cannabis category is dominated by card mills.
State medical-cannabis programs have been around for two decades, and the dominant provider model that has emerged is the “420 doctor” — a five-minute telehealth visit, a quick certification, a card issued, and the patient is sent into a dispensary with no clinical guidance, no follow-up, and no longitudinal record.
This model meets the legal requirements of state programs and almost none of the medical needs of patients. Patients with serious conditions — chronic pain, refractory anxiety, oncology supportive care, neurological disorders, end-of-life palliative care — are particularly underserved. They want a real clinician. They want a written plan. They want someone to titrate their dose, monitor their response, and adjust the regimen.
The gap, stated plainly
There is almost no premium category in medical-cannabis clinical care. There are card mills at one end and academic medical centers (which generally refuse to engage with cannabis at all) at the other. Materia occupies the missing middle: a real practice that takes cannabis medicine seriously, with the clinical rigor of any other specialty consultation.
03 · Positioning statement
Where Materia stands.
For patients with a serious condition who are considering cannabis as part of their care, Materia is a longitudinal medical practice that prescribes cannabis only where the evidence supports it — with the same clinical rigor any other specialty consultation would receive.
Positioning statement v1 · locked
The position decoded
| Element | Meaning |
|---|---|
| For patients with a serious condition | The audience is condition-led, not category-curious. The patient already has a diagnosis. Cannabis enters as a possible therapeutic answer. |
| Considering cannabis as part of their care | Patient-centered framing. The patient is the decision-maker; the physician informs the decision. |
| A longitudinal medical practice | Not a card mill. Initial consult, written plan, follow-up cadence, durable clinical record. |
| Prescribes cannabis only where the evidence supports it | Conservative clinical posture. When the evidence is thin, the physician says so. When another therapy has stronger evidence, the physician recommends that instead. |
| With the same clinical rigor any other specialty consultation would receive | The peer reference is not the dispensary or the card mill — it is the practice of a board-certified specialist in pain medicine, palliative care, or psychiatry. |
04 · Patient audience
Who Materia is for.
Primary — The Serious-Condition Patient
35–75. Has a diagnosis. Wants a clinician, not a clerk.
Lives in CA, NY, or FL. Has chronic pain, sleep disorder, refractory anxiety, oncology-related symptoms, neurological condition, or end-of-life palliative needs. Often referred by a primary care physician who acknowledges cannabis may help but doesn’t feel qualified to manage it.
- Wants a written plan and follow-up
- Will pay $350 for an initial consultation
- Distrusts the “quick card” model
- Is often skeptical of cannabis and needs evidence-based guidance
Secondary — The Caregiver
45–65. Booking on behalf of a parent or spouse.
Often the adult child of a patient with advanced cancer, dementia, or chronic pain. Coordinates the patient’s care across multiple specialists. Wants Materia to integrate cleanly into the existing care team — not stand outside it.
- Will share Materia care plans with the patient’s primary oncologist or PCP
- Values communication with other clinicians
- Pays out of pocket but tracks receipts for HSA / tax purposes
Who Materia is not for
The 21–28 recreational user looking for a state card. The patient seeking a five-minute certification with no clinical relationship. The patient who has already decided what they want and is looking for a physician’s signature to acquire it. These patients are well served by existing card-mill providers. Materia is not for them, and the practice should never twist itself to chase them.
05 · Competitive frame
How Materia sits against the field.
| Provider type | Their model | Where Materia differs |
|---|---|---|
| Card-mill telehealth (NuggMD, Veriheal, Leafwell) | 5–15 minute visit, certification, no follow-up. ~$100–200 per visit. | Materia spends 45 minutes on the first visit and sees the patient quarterly. The unit economics are deliberately different. |
| Academic medical centers | Generally refuse to certify patients due to federal/institutional risk. Refer out. | Materia is the practice the academic specialist refers to when they cannot certify in-house. |
| Specialty pain / psych / palliative practices | Some integrate cannabis informally; few certify or write structured plans. | Materia partners with these practices as a referral specialist. Materia owns the cannabis-specific portion of the care plan and reports back to the referring physician. |
| Concierge medical clinics (One Medical, Forward, Parsley Health) | Premium primary care; rarely engage with cannabis as a clinical tool. | Materia is what these concierge practices wish they could offer in-house. |
06 · Brand promise & pillars
What Materia promises — and how it keeps the promise.
Brand promise
Real clinical care. Real time. Real follow-up.
Pillar 01
Clinical, not transactional
Every patient gets a 45-minute initial consultation with a board-certified physician. The physician takes a full history, reviews existing medications, and may decline to certify if cannabis is contraindicated.
Pillar 02
Evidence-led
The clinical team maintains an internal evidence matrix updated quarterly: condition, evidence grade, recommended starting dose, contraindications. Where evidence is weak, we say so. Where another therapy is better-evidenced, we recommend that instead.
Pillar 03
Longitudinal, not one-shot
The relationship doesn’t end with the card. Quarterly follow-ups. Adjustments to the plan. Coordination with the patient’s primary care physician, oncologist, or pain specialist. A durable clinical record.
07 · Naming rationale
Why Materia.
The name is borrowed from materia medica — the Latin term for the body of knowledge concerning the therapeutic properties of any substance used for healing. The phrase has been used in Western medicine since Dioscorides in the first century CE. It signals scholarly clinical heritage and explicitly frames the practice around medicinal substances generally, not cannabis specifically.
Names considered
| Name | Strength | Why not chosen |
|---|---|---|
| Materia | References materia medica. Scholarly. Cannabis-not-mentioned. URL securable. Trademark clear in medical class. | Chosen. |
| Regimen | Names the clinical plan. | Reads dietary / weight-loss. |
| Therapeia | Greek root for therapy. Scholarly. | Hard to pronounce. Easy to misspell. |
| Compass | Suggests clinical guidance. | Already a major mental-health DTC brand (Compass Pathways). |
| Tincture | References medical preparation. | Cannabis-specific category cue. Too narrow. |
| Care | Plain-spoken. | Too generic. Many primary-care startups. |
URL: materiamedical.com (primary), materia.health (secondary). Trademarks: filed in Class 44 (medical services) in CA, NY, FL. Sister filings in Class 41 (educational content) and Class 9 (telehealth software).
08 · Voice & tone
How Materia speaks.
Materia’s voice is borrowed from three documents the audience already trusts: a physician’s chart note, a published clinical guideline, and a Mayo Clinic patient-education handout. The voice is calm, evidence-led, plain-spoken. It never sells. It informs. The reader should feel they are reading something a doctor wrote, not something a marketer wrote.
| Context | Do | Don’t |
|---|---|---|
| Homepage hero | Integrative medical care for patients considering cannabis as therapy. | Discover the most innovative medical marijuana experience! |
| Consultation page | The initial consultation is 45 minutes. Bring your medication list and a written description of your symptoms. | Get your medical card today in just five minutes! |
| Patient handout | For sleep disorders, the available evidence on cannabis is mixed. Your physician will review the evidence with you. | Cannabis is a revolutionary, best-in-class sleep aid. |
| Email subject | Your Q2 follow-up is scheduled for May 14. | You won’t believe what we’ve added to our practice! |
| Referring-physician letter | Patient was seen 2026-03-14 for evaluation of chronic neuropathic pain. The care plan is attached. Cannabis was discussed; the patient declined to start at this time. | Excited to disrupt the legacy pain-management space with our cutting-edge cannabis solutions! |
Banned vocabulary
elevate, unlock, disrupt, innovate, best-in-class, revolutionary, game-changing, journey, vibes, exclusive, medical marijuana (use cannabis), 420, dank, fire, magic, miracle, cure. If a word would be at home in a wellness influencer’s caption, it is not at home at Materia.
Important
All patient-facing content must include the standing disclaimer: “Information on this site is not a substitute for individualized medical advice. Speak with your physician before starting any new therapy.”
09 · Service architecture
What Materia sells.
| Service | Description | Investment |
|---|---|---|
| Initial consultation | 45 minutes with a board-certified physician. Full history, medication review, written care plan. State certification issued at physician’s discretion. | $350 |
| Quarterly follow-up | 20 minutes. Plan adjustment, response monitoring, side-effect review. | $150 |
| Referring-physician coordination | Direct written communication with the patient’s primary care, oncologist, or specialist. Care-plan shared on patient’s authorization. | Included |
| Telehealth program | Licensed in CA, NY, FL. Same standard of care as in-person. Conducted via Materia’s HIPAA-compliant platform. | Same pricing |
| Caregiver consultation | For family members of patients who cannot attend independently. 30 minutes. Plan education, dose-administration training. | $200 |
10 · Patient programs
The five clinical programs.
Materia organizes its clinical work into five condition-specific programs. Each has its own evidence brief, dosing reference, and outcome-tracking protocol.
| Program | Conditions served | Evidence posture |
|---|---|---|
| Chronic pain | Neuropathic pain, fibromyalgia, post-surgical pain, arthritis-related pain. | Moderate-to-good evidence for adjunctive use in neuropathic pain. Mixed for nociceptive. |
| Oncology supportive | Chemotherapy-induced nausea, cachexia, cancer-related pain, sleep disturbance during treatment. | Strong evidence for nausea (synthetic THC analogues), moderate for cachexia and sleep. |
| Sleep | Primary insomnia, sleep maintenance disorder. | Mixed. Often a third- or fourth-line option after other interventions. |
| Anxiety | Generalized anxiety, performance anxiety, PTSD-related symptoms. | Conservative posture. CBD-dominant formulations preferred. Risk of THC-induced anxiety in some patients. |
| Neurological | Multiple sclerosis spasticity, refractory epilepsy (pediatric referrals only), Parkinson’s-related tremor and sleep. | Strong for MS spasticity. Pediatric epilepsy referred to specialty centers; Materia provides adult care plans only. |
11 · Brand brief for visual identity
The visual identity that this strategy requires.
Reference points
- Mayo Clinic patient-education handouts
- NEJM journal cover typography
- Aesop apothecary packaging (clinical-as-beauty)
- One Medical clinic interiors (calm, light-wood, residential-feeling)
- The British Pharmacopoeia title pages
Anti-references
- Cannabis leaf iconography of any kind
- Stethoscope / caduceus / red-cross medical clipart
- “Medical marijuana” stock photography
- Bright primary-color tech-startup illustration
- Doctor-in-white-coat hero photography
- Wellness-influencer aesthetic (avocado backgrounds, etc.)
Required system elements
- Wordmark. Lowercase Crimson Pro or similar scholarly serif. Set tight. A small muted-teal accent dot follows the word on patient materials.
- Palette. Clinical white substrate. Deep teal-ink (#1F2E2E) as the primary type color. Muted teal (#4B7C7E) for headings and accents. Soft amber (#C8956A) reserved exclusively for safety callouts (“consult before starting” type notices).
- Typography. Crimson Pro for headings and editorial body. Inter for UI and longer-form content. JetBrains Mono for dose values, condition codes, and structured care-plan fields.
- Patient materials. Uncoated cotton paper. Muted teal accent bar. Single-color print. No glossy varnish. The care plan and welcome packet should feel like a Goop Health membership crossed with a medical-school diploma.
- Photography. Clinic interiors, hands holding documents, still-life of patient materials. No patient or physician faces shown unprompted. Faces only appear on the “Doctors” page, where they are sanctioned and consensual.
- Telehealth UI. Same palette as print. The screen feels like a printed care plan, not an app. No bright primary buttons, no notification badges, no “gamified” progress meters.
12 · Next steps
What comes after this Sprint.
| Phase | Engagement | Timeline | Investment |
|---|---|---|---|
| 02 | Visual Identity System (wordmark, palette, type, photo direction, guidelines) | 5 weeks | $14,000 |
| 03 | Patient materials system (welcome packet, care plan, condition handouts, dosing references) | 6 weeks | $18,000 |
| 04 | Telehealth platform UI design (intake, consultation room, follow-up scheduling) | 8 weeks | $32,000 |
| 05 | Clinic signage + interior wayfinding (Hayes Valley flagship) | 4 weeks | $11,000 |
The strategy you’ve approved here is the foundation of every patient touchpoint that follows. If a page, a handout, or a screen doesn’t pass the test of calm, evidence-led, plain-spoken, it isn’t Materia yet.